Stryker Corporation
Stryker Announces Retirement of CFO Glenn Boehnlein and Promotion of Preston Wells
Summary
On January 28, 2025, Stryker Corporation announced the retirement of its Vice President and Chief Financial Officer, Glenn S. Boehnlein, effective April 1, 2025. Preston W. Wells, currently serving as Vice President and Group Chief Financial Officer for Orthopaedics, will be promoted to Vice President and Chief Financial Officer in his place. Boehnlein will continue as an advisor to the CEO until March 31, 2026, and Wells will assume his new role on April 1, 2025.
Profitelligence Alerts
Get alerts for SYK
Be first to know when Stryker Corporation files with the SEC.
Filing Categories
Exhibits (3)
Advertisement
About Stryker Corporation
Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.
Official SEC Documents
Advertisement